Phase II study of antineoplastons A10 and AS2-1 infusions in patients with ependymoma
Phase of Trial: Phase II
Latest Information Update: 21 Feb 2017
At a glance
- Drugs Antineoplaston A10/antineoplaston AS2-1 (Primary)
- Indications Ependymoma
- Focus Adverse reactions; Therapeutic Use
- 28 Dec 2016 Status changed from active, no longer recruiting to discontinued.
- 05 Dec 2007 New trial record.